Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025
Nuwellis (Nasdaq: NUWE), a medical technology company specializing in fluid overload treatments, has scheduled its second quarter 2025 financial results announcement for August 12, 2025. The company will host a conference call and webcast at 9:00 AM ET to discuss the results and provide business updates.
Investors can access the live webcast through the company's investor relations website at ir.nuwellis.com, or join the conference call by dialing 1-800-245-3047 (U.S.) or 1-203-518-9765 (international) using conference ID: NUWEQ2.
Nuwellis (Nasdaq: NUWE), un'azienda di tecnologia medica specializzata nei trattamenti per il sovraccarico di liquidi, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 12 agosto 2025. La società terrà una conference call e una webcast alle 9:00 AM ET per discutere i risultati e fornire aggiornamenti aziendali.
Gli investitori potranno accedere alla diretta webcast tramite il sito web delle relazioni con gli investitori all'indirizzo ir.nuwellis.com, oppure partecipare alla conference call chiamando il numero 1-800-245-3047 (USA) o 1-203-518-9765 (internazionale) utilizzando il codice di conferenza: NUWEQ2.
Nuwellis (Nasdaq: NUWE), una empresa de tecnología médica especializada en tratamientos para la sobrecarga de líquidos, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el 12 de agosto de 2025. La compañía realizará una llamada conferencia y una transmisión en vivo a las 9:00 AM ET para discutir los resultados y proporcionar actualizaciones comerciales.
Los inversores pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de la empresa en ir.nuwellis.com, o unirse a la llamada conferencia marcando 1-800-245-3047 (EE.UU.) o 1-203-518-9765 (internacional) usando el ID de conferencia: NUWEQ2.
Nuwellis (나스닥: NUWE)는 체액 과부하 치료를 전문으로 하는 의료 기술 회사로, 2025년 8월 12일에 2025년 2분기 재무 실적 발표를 예정하고 있습니다. 회사는 결과를 논의하고 사업 업데이트를 제공하기 위해 동부 시간 기준 오전 9시에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
투자자들은 회사의 투자자 관계 웹사이트 ir.nuwellis.com을 통해 라이브 웹캐스트에 접속할 수 있으며, 컨퍼런스 ID: NUWEQ2를 사용하여 1-800-245-3047 (미국) 또는 1-203-518-9765 (국제)로 전화하여 컨퍼런스 콜에 참여할 수 있습니다.
Nuwellis (Nasdaq : NUWE), une entreprise de technologie médicale spécialisée dans les traitements de surcharge liquidienne, a programmé l'annonce des résultats financiers du deuxième trimestre 2025 pour le 12 août 2025. La société tiendra une conférence téléphonique et une diffusion en direct à 9h00 ET pour discuter des résultats et fournir des mises à jour commerciales.
Les investisseurs peuvent accéder à la diffusion en direct via le site web des relations investisseurs de la société à ir.nuwellis.com, ou rejoindre la conférence téléphonique en composant le 1-800-245-3047 (États-Unis) ou le 1-203-518-9765 (international) en utilisant l'identifiant de conférence : NUWEQ2.
Nuwellis (Nasdaq: NUWE), ein Medizintechnikunternehmen, das sich auf die Behandlung von Flüssigkeitsüberladung spezialisiert hat, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für den 12. August 2025 geplant. Das Unternehmen wird um 9:00 Uhr ET eine Telefonkonferenz und ein Webcast abhalten, um die Ergebnisse zu besprechen und Geschäftsaktualisierungen zu geben.
Investoren können den Live-Webcast über die Investor-Relations-Website des Unternehmens unter ir.nuwellis.com verfolgen oder an der Telefonkonferenz teilnehmen, indem sie 1-800-245-3047 (USA) oder 1-203-518-9765 (international) anrufen und die Konferenz-ID: NUWEQ2 verwenden.
- None.
- None.
MINNEAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter 2025 on August 12, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update.
To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-245-3047 (U.S) or 1-203-518-9765 (international) and using the conference ID: NUWEQ2. An audio archive of the webcast will be available following the call on the Investors page at https://ir.nuwellis.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a commercial-stage medical technology company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland. For more information visit ir.nuwellis.com or visit us on LinkedIn or X.
About the Aquadex SmartFlow® System
The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.
CONTACTS
INVESTORS:
Robert Scott
Chief Financial Officer
ir@nuwellis.com
MEDIA:
Leah McMullen
Director of Communications
Leah.mcmullen@nuwellis.com
FAQ
When will Nuwellis (NUWE) report Q2 2025 earnings?
How can investors access Nuwellis (NUWE) Q2 2025 earnings call?
What time is Nuwellis (NUWE) Q2 2025 earnings call?
What does Nuwellis (NUWE) company do?
